TY  - GEN
AU  - Exaire,J E
AU  - Lincoff,A M
TI  - Should glycoprotein IIb/IIIa inhibitors be used during all percutaneous coronary interventions? Yes
SN  - 1538-7933
PY  - 2004///0917
KW  - Abciximab
KW  - Angioplasty, Balloon, Coronary
KW  - methods
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Cost-Benefit Analysis
KW  - Humans
KW  - Immunoglobulin Fab Fragments
KW  - Platelet Aggregation Inhibitors
KW  - Platelet Glycoprotein GPIIb-IIIa Complex
KW  - antagonists & inhibitors
KW  - Safety
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1111/j.1538-7836.2004.00559.x
ER  -